Correlation Between Prometheus Biosciences and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Prometheus Biosciences and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prometheus Biosciences and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prometheus Biosciences and Akero Therapeutics, you can compare the effects of market volatilities on Prometheus Biosciences and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prometheus Biosciences with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prometheus Biosciences and Akero Therapeutics.
Diversification Opportunities for Prometheus Biosciences and Akero Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Prometheus and Akero is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Prometheus Biosciences and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Prometheus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prometheus Biosciences are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Prometheus Biosciences i.e., Prometheus Biosciences and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Prometheus Biosciences and Akero Therapeutics
If you would invest 2,971 in Akero Therapeutics on August 28, 2024 and sell it today you would earn a total of 206.00 from holding Akero Therapeutics or generate 6.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Prometheus Biosciences vs. Akero Therapeutics
Performance |
| Timeline |
| Prometheus Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Akero Therapeutics |
Prometheus Biosciences and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prometheus Biosciences and Akero Therapeutics
The main advantage of trading using opposite Prometheus Biosciences and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prometheus Biosciences position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Prometheus Biosciences vs. Apellis Pharmaceuticals | Prometheus Biosciences vs. Akero Therapeutics | Prometheus Biosciences vs. Immunovant | Prometheus Biosciences vs. Madrigal Pharmaceuticals |
| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance |